New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide

12Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems, such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence.

Cite

CITATION STYLE

APA

Escudero, V. J., Mercadal, J., Molina-Andújar, A., Piñeiro, G. J., Cucchiari, D., Jacas, A., … Poch, E. (2022). New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide. Frontiers in Nephrology. Frontiers Media SA. https://doi.org/10.3389/fneph.2022.879766

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free